A noteworthy investigation has revealed a decline in FNDC5/Irisin levels within the brain and cerebrospinal fluid (CSF) of AD patients, but not in plasma, suggesting a distinct decrease within the central nervous system (CNS) [21]. This evidence concerns the gene FNDC5 and Alzheimer disease.